Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pallav Bhatnagar

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
JAMA Cardiology|March 12, 2018
ADCY9 Genetic Variants and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease: A Nested Case-Control StudySteven E Nissen, Sreekumar G Pillai, Stephen J Nicholls, et al.
Hepatology Communications|May 16, 2018
Coding variants in <i>PNPLA3</i> and <i>TM6SF2</i> are risk factors for hepatic steatosis and elevated serum alanine aminotransferases caused by a glucagon receptor antagonistCristina B Guzman, Suman Duvvuru, Anthony Akkari, et al.
British Journal of Haematology|August 20, 2013
Acute chest syndrome is associated with single nucleotide polymorphism-defined beta globin cluster haplotype in children with sickle cell anaemiaChristopher J Bean, Sheree L Boulet, Genyan Yang, et al.
Diabetes|August 24, 2021
Genetically Predicted Glucose-Dependent Insulinotropic Polypeptide (GIP) Levels and Cardiovascular Disease Risk Are Driven by Distinct Causal Variants in the <i>GIPR</i> RegionNicholas Bowker, Robert Hansford, Stephen Burgess, et al.
Hepatology Communications|December 14, 2019
A Pilot Genome-Wide Analysis Study Identifies Loci Associated With Response to Obeticholic Acid in Patients With NASHSamer Gawrieh, Xiuqing Guo, Jingyi Tan, et al.
Nature Genetics|June 2, 2009
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillinAnn K Daly, Peter T Donaldson, Pallav Bhatnagar, et al.
The Lancet. Diabetes & Endocrinology|December 17, 2022
Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trialsAdem Y Dawed, Andrea Mari, Andrew Brown, et al.
Plos One|May 5, 2012
A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemiaJacqueline N Milton, Paola Sebastiani, Nadia Solovieff, et al.
Scientific Reports|April 29, 2026
Unraveling the physiological impact of ANGPTL8 loss-of-function variants in humansArkan Abadi, Yan Q Chen, Shareef Khalid, et al.
Plos Genetics|July 9, 2011
Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individualsDan E Arking, M Juhani Junttila, Philippe Goyette, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
JAMA Cardiology|March 12, 2018
ADCY9 Genetic Variants and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease: A Nested Case-Control StudySteven E Nissen, Sreekumar G Pillai, Stephen J Nicholls, et al.
Hepatology Communications|May 16, 2018
Coding variants in <i>PNPLA3</i> and <i>TM6SF2</i> are risk factors for hepatic steatosis and elevated serum alanine aminotransferases caused by a glucagon receptor antagonistCristina B Guzman, Suman Duvvuru, Anthony Akkari, et al.
British Journal of Haematology|August 20, 2013
Acute chest syndrome is associated with single nucleotide polymorphism-defined beta globin cluster haplotype in children with sickle cell anaemiaChristopher J Bean, Sheree L Boulet, Genyan Yang, et al.
Diabetes|August 24, 2021
Genetically Predicted Glucose-Dependent Insulinotropic Polypeptide (GIP) Levels and Cardiovascular Disease Risk Are Driven by Distinct Causal Variants in the <i>GIPR</i> RegionNicholas Bowker, Robert Hansford, Stephen Burgess, et al.
Hepatology Communications|December 14, 2019
A Pilot Genome-Wide Analysis Study Identifies Loci Associated With Response to Obeticholic Acid in Patients With NASHSamer Gawrieh, Xiuqing Guo, Jingyi Tan, et al.
Nature Genetics|June 2, 2009
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillinAnn K Daly, Peter T Donaldson, Pallav Bhatnagar, et al.
The Lancet. Diabetes & Endocrinology|December 17, 2022
Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trialsAdem Y Dawed, Andrea Mari, Andrew Brown, et al.
Plos One|May 5, 2012
A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemiaJacqueline N Milton, Paola Sebastiani, Nadia Solovieff, et al.
Scientific Reports|April 29, 2026
Unraveling the physiological impact of ANGPTL8 loss-of-function variants in humansArkan Abadi, Yan Q Chen, Shareef Khalid, et al.
Plos Genetics|July 9, 2011
Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individualsDan E Arking, M Juhani Junttila, Philippe Goyette, et al.
Pageof 4